Search

Search Constraints

You searched for: Author/Creator Shoushtari, Alexander N.

Search Results

1. A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma. Issue 3 (June 2016)

2. Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study). Issue 10 (1st April 2022)

3. Anorectal Mucosal Melanoma in the Era of Immune Checkpoint Inhibition: Should We Change Our Surgical Management Paradigm?. Issue 5 (26th January 2021)

4. Anorectal Mucosal Melanoma in the Era of Immune Checkpoint Inhibition: Should We Change Our Surgical Management Paradigm?. Issue 5 (May 2021)

5. Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma. (January 2021)

6. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (1st September 2022)

7. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (20th May 2022)

8. Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia. Issue 1 (January 2021)

9. Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma. Issue 1 (February 2017)

10. Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies. Issue 21 (17th August 2016)